Spine infections require a multidisciplinary approach to be treated and solved. A guide line to drive physicians in the deep complexity of such a disease is extremely helpful. SIMP suggests a flow-chart built up on clear concepts such as right and well managed antibiotic therapy, sound stability of the spine, correct and smart use of the standard and functional imaging techniques, such as OS FDG PET/CT. In 16 months a total of 41 patients have been treated for spondylodiscitis, discitis and vertebral osteomyelitis by our team of physicians and 25 patients have been enrolled in a prospective study whose target is the assessment of the SIMP flow-chart and of every single aspect that characterize it.
Spine infections may involve intervertebral disc, bone, paravertebral tissues. They are rare diseases, difficult to manage. Late diagnosis is usual. Treatment lasts months. Residual defects are quite common. From 1999 to 2009, 130 patients have been treated. The experience showed the absolute need of a multidisciplinary approach. In our city-area a group of spine surgeons, nuclear medicine and infective disease specialists, together with interventional radiologists and anaesthesiologists have founded in October 2009 a work panel identified as SIMP (Spine Infection Multidisciplinary Management Project) and started to prospectively collect data on spine infections. A flow-chart has been developed on the basis of a previous published one[ 1], but characterized by important new concepts, with the aim to guide physicians in the diagnostic and treatment process ofa complex disease. The flow-chart is also a way to uniform the management of the disease and help scientific evaluation, since ethical randomized study are extremely difficult to be realized [2] .
MATERIALS AND METHODS
Since October 2009 patients affected by spine infections with involvement of the intervertebral disc (discitis), bone (vertebral osteomyelitis/spondylitis), both of them with/without paravertebral tissues (spondylodiscitis) were enrolled in a clinical case series study based on prospective data collection, clear inclusion and exclusion criteria, consecutive patient enrolment and a priori defined study protocol following SIMP algorithm (fig.I). Inclusion criteria have been defined as patient affected by spine infections, managed by SIMP physicians in every clinical aspect (diagnosis, medical and surgical treatment), agreement on informed consent with the will to be followed in time. Exclusion criteria have been considered: -Surgical Site Infection (SSI);patients partially managed by SIMP team; -refusal to informed consent or to be followed in time; -pregnancy or the will to be pregnant in 1-2 years. Data are recorded in a secured database.
Key point of the flow-chart are: I) MRI with gadolinium as the diagnostic gold standard; 2) fl8-FDO PET/CT at time o and after 2-4 weeks medical therapy or after 6-12 weeks from surgery in the evaluation of the treatment efficacy; when MRI doesn't help in diagnosis, PET/CT can also help and differentiate between high stage degenerative inflammation and infection. 3) CT-guided 80 caliber-Trocar Biopsy performed by interventional radiologist before the beginning of antibiotic therapy in the stable patient for histologic and microbiologic diagnosis (in unstable/septic patient antibiotic aspecific therapy can be started once diagnosis is done). 4) Antibiotic therapy.
In our management algorithm first-line regimens are: A) the combination Rifampicin + high-dose Levofloxacin in the treatment of community-acquired infections (also providing good action spectrum to the Enterobacteriaceae in patients with a history of recurrent infections of genito-urinary or gastrointestinal system) or microbiologically documented infections by Methicillin-sensitive Staphylococcus spp. B) the combination Rifampicin + high doses Teicoplanin in the treatment of post-surgical infections or microbiologically documented infections by Methicillin-resistant Staphylococcus spp. C) Patients with Tubercolar (TB) spine lesion should receive a regimen containing 9-12 months of Rifampicin: 2HRZE/7-IOHR (WHO, 2003, Guidelines for National Programmes: 2 months with Isoniazid, Rifampicin, Pyrazinamide and Ethambutol / 7-10 months with Isoniazid and Rifampicin), but SIMP protocol uses Levofloxacin in place of Ethambutol. 5) Surgical Treatment. It is indicated only if patient respond to eligibility criteria such as: wide abscess, progressive neurologic signs, instability/deformity, need for diagnosis, conservative treatment failure. Aims are surgical debridement, as wider as possible, neurologic decompression, biomechanical stability (with spinal instrumentation in the majority of the cases), with no worry on recurrence due to adherence to metallic implant. SIMP preferred approach is the posterior one. Mininvasive stabilization technique is also taken into account in cases that need to be mobilized soon, with no abscess and with the chance to insert pedicular screws in healthy tissue.
RESULTS
In 16 months 25 patients have been enrolled, 17 males and 8 females, range 20-85, median 64 years old. Results presented are preliminary and incomplete. Among this cohort 17 patients were affected by pyogenic lesion (diagnosis made by histologic/microbiologic examination after biopsy, blood culture, isolation from other foci), 8 patients by Tubercolar lesion. Four patients were affected by a iatrogenic spondylodiscitis. Ten patients have been submitted to surgery: 3 abscess drainage, 5 debridement and posterior stabilization, 1 debridement and stabilization through double approach, 1 posterior approach mini-invasive stabilization (Fig.2 ). Among the case series 18 patients can be already defined healed on the basis of lab test (ESR and CRP negative) and clinic evidence, even if the follow-up (FU) is too short (3-16 months) for a consistent evaluation; 7 patients are still receiving treatment.
The most interesting result so far is connected with the PET/CT study, that was completed in 12 cases with non diagnostic cultural exam after biopsy. Maximum Standardized Uptake Value (SUV) ranged at diagnosis between 4.1 and 12.3 (average 7.3). Nine patients showed a significant reduction in SUV-max (mean difference between PETl and PET2 was 3.5, Fig.3 ) while 3 patients not at interim PET (SUV-max increased on average 0.7). After variation in drugs therapy, every non-responder patient improved, showing a decreasing SUV-max (mean difference between PET2 and PET3 was 3.2). All the patients are showing a good clinical response during FU check, with persistent negative values of the CRP.
DISCUSSION

Functional Imaging in Spine Infections
Since some years ago, the diagnostic flow-chart of cancer patients is frequently integrated with functional imaging such as FDG-PET/CT (Fluorodeoxyglucose-Positron Emission Tomography/Computerized Tomography). It is based on the measurement of the metabolic activity of organs, tissues or lesions in a non invasive and semi-quantitative way, through the SUV. The SUV is correlated to the amount of a tracer taken up in a specific area, which is proportional to the metabolic activity. The most common tracer is FDG, a glucose analogue labelled with 18F, a positron emitter radioactive isotope which renders the tracer detectable by the tomograph crystals. The last generation PET tomographs are integrated also with a diagnostic CT system, aimed to produce an accurate anatomical map that is the base for hypermetabolic areas' anatomical localization. SUV very easily allows the identification of infection sites with a very good sensitivity, increasing the diagnostic accuracy of MR especially when it is impossible to distinguish between severe degenerative processes (negative at FDG PET/CT) and infective processes [3] [4] [5] . Furthermore, due to PET great sensitivity, it is possible to very soon measure an eventual response to antibiotic therapy (SUV reduction) confirming a correct therapeutic choice or indicating the need of a change in therapy in case of stability or increase in SUV.This is really useful in patients with negative culture exam and without a significant rise in inflammation indexes at diagnosis. In our experience, as early as 2-4 weeks after the onset of a correct antibiotic therapy, both pyogenic and tubercular discitis showed a significant reduction in SUV, which is on average halved. This pattern has been predictive of a complete response in all the patients. Those patients who were early non responder at PET imaging, underwent a sudden change in therapy. This management led to the same good results as for early responder patients, saving time, reducing toxicity and decreasing the risk of vertebral collapses due to ineffective therapy [6] . The optimal performances of PET in spine infections are related to the great sensitivity and specificity, due to the particular features of the spine. Degenerative processes are not, in fact, hypermetabolic and therefore false positive results are basically due only to recent vertebral collapses, usually clinically well known. A mild tracer uptake may be present in some cases beside prosthesis or bone implants as an expression of a Stop orthop aedic restrict ions when there a re sig ns of bone fusion and mec ha nica l pain reso lution "
In case of con se rvat ive trea tme nt failur e go back and consider su rgery local irritative process [7] . Another advantage of FDG-PET/CT is the whole body field of view. This ensures, without any change in dosimetry to the patient, a complete evaluation of the whole spine but also of other organs and soft tissues, very useful for multifocal infections. In the future the functional PET imaging may also guide the spine biopsy by indicating the hotter areas and potentially increasing the biopsy sensitivity and accuracy. Antibiotic Therapy _ Spine Infection is a clinical setting where there is still high uncertainty on choice of medical treatment regimens, in terms of molecules, doses and treatment times. The paucity of controlled trials and observational studies adequately powered contributes to the high therapeutic empiricism still found in the clinical practice. Spondylodiscitis probably represents the best setting where to evaluate effectiveness ofany antimicrobial regimen, because within the bone infections universe they represent those with the smallest variability in terms of clinical findings, patients' age, need for surgery [8] . Rifampicin is the backbone ofour regimen (in association to either Teicoplanin or Levofloxacin). It is an excellent antistaphylococcal molecule, has an excellent bone penetration, good oral bioavailability, excellent efficacy against forms of Staphylococcus spp "small colony variants", it exerts a synergic action with both glycopeptides and quinolones and also represents an effective stabilizer of the risk of induced resistance against quinolones [9] . Levofloxacin is the most suitable molecule for this class of drugs for its excellent oral bioavailability (higher than ciprofloxacin), which allows an oral ab initio, its optimal spectrum of activity (more extended than ciprofloxacin towards Grampositives and more extended than Moxifloxacin towards Gram-negatives) and its bone penetration coefficient[lO, II]. Teicoplanin has a good anti-MRSA activity, moderate bone penetration (although better than Vancomycin) and, thanks to its long half-life, allows a three times a week administration regimen [12] [13] [14] [15] .
The management of spinal tuberculosis IS controversial. Modem chemotherapy has significantly decreased mortality, but morbidity remains high. Surgery plays a role in the management of the deformity but also help and strengthen medical treatment in selected cases, such as wide abscesses and unstable lesions (16] . The mainstay of medical treatment is chemotherapy with at least Isoniazid, Rifampicin, and Pyrazinamide for 6-12 month [17] . The SIMP choice to use Levofloxacin in place of ethambutol in the standard regimen is motivated on the basis of the better penetration into bone tissue by quinolones rather than ethambutol.
Surgical Treatment _ Historically spondylodiscitis have always been treated in a conservative way, with the exception of residual deformity correction. Nowadays the improved antibiotic and biomechanical knowledge and the patient request for rapid return to daily life are finding a new role for surgery. Stability of the affected motion segment in the spine has a key-role in the infection healing. This was usually obtained in the past by simple bed rest or hard to bear, long lasting cast treatment. At present time a general consensus is spreading among spine surgeons on the safe use of spinal metal instrumentations to stabilize infected vertebrae [18] . Actually, the debridement together with the chance to perform an adequate antibiotic therapy based on antibiogram after open biopsy, clear the local infection enough to use pedicle screws and rods locally. They have however to be inserted in healthy tissue close to the lesion and not in the lesion itself. The instrumentation create the stable and adequate environment for the antibiotics to eradicate the infection with no micromovements or instability, solving also the mechanical pain of the patient and allowing a rapid return to load bearing and deambulation, avoiding risks related to prolonged bed rest. In this context mini-invasive stabilization finds a role, indicated every time debridement is not necessary and patient must or want to avoid even the usual 8 weeks bed rest period.
